Date published: 2026-3-31

1-800-457-3801

SCBT Portrait Logo
Seach Input

C8orf70 Inhibitors

C8orf70 inhibitors would be classified as molecules designed to inhibit the protein encoded by the C8orf70 gene, which is a member of the open reading frame (ORF) family of proteins. The specific function of C8orf70 is not universally characterized, but proteins within this family often have roles in various cellular processes due to their coding potential. The gene's designation 'C8' likely refers to its chromosomal location, indicating that it is situated on chromosome 8. Inhibitors targeting C8orf70 would interact with this protein, disrupting its normal biological function. The development of such inhibitors would necessitate a detailed understanding of the protein's structure, its interaction with other cellular components, and the consequences of its activity within the cell. This could involve delineating the protein's active sites, domains, or motifs that are crucial for its function and identifying how these structural elements contribute to the protein's role in cellular processes.

In the discovery phase of C8orf70 inhibitors, scientists would employ a variety of biophysical and biochemical techniques to unravel the protein's structure and function. Methods such as X-ray crystallography, NMR spectroscopy, or cryo-electron microscopy might be utilized to obtain high-resolution images of C8orf70, revealing its three-dimensional conformation. The information gleaned from these structural studies would be instrumental in identifying potential binding sites that are amenable to small molecule interaction. Once such sites are identified, a process of high-throughput screening could be initiated, testing large libraries of chemical compounds for their ability to bind to and inhibit C8orf70. Such screening assays would be designed to detect interactions between C8orf70 and potential inhibitors, often using fluorescent or colorimetric readouts to measure binding affinities.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A cytidine analog that incorporates into DNA and RNA, leading to hypomethylation of DNA, which may affect the expression of genes like ZC2HC1A.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Similar to 5-azacytidine, it causes DNA hypomethylation and could alter the expression of ZC2HC1A by changing gene regulatory regions.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$53.00
$89.00
7
(1)

Known to chelate metals and could disrupt the zinc finger domains necessary for ZC2HC1A's function.

Zinc

7440-66-6sc-213177
100 g
$48.00
(0)

A metal complex which might disrupt zinc finger protein functions by altering zinc homeostasis, potentially affecting ZC2HC1A expression.

Clioquinol

130-26-7sc-201066
sc-201066A
1 g
5 g
$45.00
$115.00
2
(1)

A metal chelator that could bind zinc and affect the function and expression of zinc finger proteins like ZC2HC1A.

1,10-Phenanthroline

66-71-7sc-255888
sc-255888A
2.5 g
5 g
$23.00
$32.00
(0)

A chelating agent that can bind metal ions and might interfere with the structural integrity of zinc finger proteins.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

A diterpene triepoxide that can inhibit the transcription of various genes by targeting the transcriptional machinery, potentially affecting ZC2HC1A.

Chromomycin A3

7059-24-7sc-200907
10 mg
$260.00
(1)

A glycoside antibiotic that binds to G-C rich regions of DNA and might inhibit the binding of zinc finger transcription factors, potentially reducing ZC2HC1A expression.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Another antibiotic that binds DNA and could prevent transcription factors from binding to gene regulatory regions.

Dithizone

60-10-6sc-206031A
sc-206031
10 g
50 g
$92.00
$339.00
2
(0)

A sulfur-containing chelator that binds to heavy metals and could interfere with zinc finger protein domains.